Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4418
Source ID: NCT01514149
Associated Drug: Cjc-1134-Pc Injection
Title: Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy
Acronym:
Status: TERMINATED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT01514149/results
Conditions: Type 2 Diabetes Mellitus (T2DM)
Interventions: DRUG: CJC-1134-PC Injection|DRUG: Weekly placebo for CJC-1134-PC Injection
Outcome Measures: Primary: Glycosylated Hemoglobin Change From Baseline (CFB) to Week 18, CFB to Week 18 | Secondary: Fasting Body Weight CFB to Week 18, CFB to Week 18|Time to Hyperglycemia Rescue, 18 weeks
Sponsor/Collaborators: Sponsor: ConjuChem
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 73
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2011-09
Completion Date: 2013-03
Results First Posted: 2017-07-19
Last Update Posted: 2017-07-19
Locations: Research Site, Phoenix, Arizona, 85018, United States|Research Site, Inglewood, California, 90301, United States|Research Site, Tarzana, California, 91356, United States|Research Site, Ventura, California, 93003, United States|Research Site, Wellington, Florida, 33414, United States|Research Site, Idaho Falls, Idaho, 83404, United States|Research Site, Lexington, Kentucky, 40504, United States|Research Site, Brighton, Massachusetts, 02135, United States|Research Site, Greensboro, North Carolina, 27405, United States|Research Site, Eugene, Oregon, 97401, United States|Research Site, Altoona, Pennsylvania, 16602, United States|Research Site, East Providence, Rhode Island, 02915, United States|Research Site, Charleston, South Carolina, 29407, United States|Research Site, Taylors, South Carolina, 29687, United States|Research Site, Austin, Texas, 78758, United States|Research Site, Dallas, Texas, 75231, United States|Research Site, San Antonio, Texas, 78249, United States|Research Site, Salt Lake City, Utah, 84107, United States|Research Site, Henrico, Virginia, 23233, United States|Research Site, Vancouver, British Columbia, Canada|Research Site, Smiths Falls, Ontario, Canada|Research Site, Toronto, Ontario, Canada
URL: https://clinicaltrials.gov/show/NCT01514149

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress